Uterine Fibroid

Study Closed

Type of Study:

Heavy Menstrual Bleeding associated with Uterine Fibroids

Title of Study:

Efficacy and Safety of OBE2109 in Subjects with Heavy Menstrual Bleeding Associated with Uterine Fibroids

Short Title:

Uterine Fibroid

Study Length: 52 weeks

Target Age/Sex: 18 years and older, Female


Participants will receive at no cost: Study medication and study related procedures. Subject may also receive a stipend for time/travel related to the study.